The Association of Pretransplant CD4 Count With Post‐Kidney Transplant Infectious Outcomes Among Persons With HIV
Transplant Infectious Disease · 16.08.2026
DOI: 10.1111/tid.70290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, online erschienen am 16.08.2026. Verfasst von Rebecca H Burns und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Few studies have examined pretransplant CD4 count and risk of post‐kidney transplant (KT) infection in persons with HIV (PWH).
Methods
This multi‐center, retrospective cohort study included adult PWH undergoing KT from 2004 to 2019. The primary outcome was infection in the first year post‐KT in PWH with pretransplant CD4 < 350 cells/µL versus CD4 ≥ 350 cells/µL. Relative risk was assessed using modified Poisson modeling. Restricted mean survival time analysis was used to assess 5‐year posttransplant outcomes.
Results
Of the 75 patients included, 27% had a pretransplant CD4 < 350 cells/µL. Those with CD4 < 350 versus CD4 ≥ 350 were more likely to be hospitalized for infection in the first year (55% versus 16%, p = 0.001). There were no significant differences in relative risk of infection in the first‐year posttransplant (RR: 1.31, p = 0.053), 5‐year overall survival (87.5% vs. 93%, p = 0.49) or 5‐year graft loss (29.4% vs. 23.1%, p = 0.61) betweengroups.
Conclusion
These findings suggest that pretransplant CD4 count alone may not reflect the true risk of post‐KT infection in PWH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Ochsner Health, New Orleans, Louisiana, USA.
- Ochsner Clinical School, University of Queensland School of Medicine, New Orleans, Louisiana, USA.
Zitieren
APA
Burns, R. H., Booth, S., Marks, C. R., Durand, C. M., Hand, J., Abidi, M. Z., Malinis, M., Barnaba, B., Pavlakis, M., Krakower, D., Alonso, C. D., & Le-Mahajan, A. (2026). The Association of Pretransplant CD4 Count With Post‐Kidney Transplant Infectious Outcomes Among Persons With HIV. Transplant Infectious Disease. https://doi.org/10.1111/tid.70290
Vancouver
Burns RH, Booth S, Marks CR, Durand CM, Hand J, Abidi MZ, et al. The Association of Pretransplant CD4 Count With Post‐Kidney Transplant Infectious Outcomes Among Persons With HIV. Transplant Infectious Disease. 2026. doi:10.1111/tid.70290
BibTeX
@article{Burns2026,
author = {Burns, Rebecca H and Booth, Sara and Marks, Christin Rogers and Durand, Christine M and Hand, Jonathan and Abidi, Maheen Z and Malinis, Maricar and Barnaba, Brittany and Pavlakis, Martha and Krakower, Douglas and Alonso, Carolyn D and Le-Mahajan, Audrey},
title = {The Association of Pretransplant CD4 Count With Post‐Kidney Transplant Infectious Outcomes Among Persons With HIV},
journal = {Transplant Infectious Disease},
year = {2026},
doi = {10.1111/tid.70290}
}
EUVIMED